![Richard Davies](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Davies
Nessuna posizione attualmente
Profilo
Richard Davies served as Chairman at Capsant Neurotechnologies Ltd.
and Director at Southampton Asset Management Ltd.
He obtained an undergraduate degree from The University of Liverpool.
Precedenti posizioni note di Richard Davies
Società | Posizione | Fine |
---|---|---|
Southampton Asset Management Ltd.
![]() Southampton Asset Management Ltd. Investment ManagersFinance Southampton Asset Management Ltd (SAM) is a venture capital firm, a subsidiary of University of Southampton Holdings Ltd. The firm is headquartered in Southampton, United Kingdom. | Direttore degli Investimenti | 08/01/2011 |
Capsant Neurotechnologies Ltd.
![]() Capsant Neurotechnologies Ltd. Pharmaceuticals: MajorHealth Technology Capsant Neurotechnologies Ltd. provided pre-clinical assay services to the drug development industry. It offered in-vitro tissue based screening technologies based on ex-vivo tissues and reaggregated 3D systems. The firm significantly reduced the costs associated with pre-clinical drug development and shortening the overall decision process in the selection of lead candidates for clinical evaluation. The company was founded by Lars Eric Sundstrom, Ashley Ker Pringle and John Edward Chad on June 21, 2002 and was headquartered in Gray's Inn, the United Kingdom. | Presidente | - |
Formazione di Richard Davies
The University of Liverpool | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Southampton Asset Management Ltd.
![]() Southampton Asset Management Ltd. Investment ManagersFinance Southampton Asset Management Ltd (SAM) is a venture capital firm, a subsidiary of University of Southampton Holdings Ltd. The firm is headquartered in Southampton, United Kingdom. | Finance |
Capsant Neurotechnologies Ltd.
![]() Capsant Neurotechnologies Ltd. Pharmaceuticals: MajorHealth Technology Capsant Neurotechnologies Ltd. provided pre-clinical assay services to the drug development industry. It offered in-vitro tissue based screening technologies based on ex-vivo tissues and reaggregated 3D systems. The firm significantly reduced the costs associated with pre-clinical drug development and shortening the overall decision process in the selection of lead candidates for clinical evaluation. The company was founded by Lars Eric Sundstrom, Ashley Ker Pringle and John Edward Chad on June 21, 2002 and was headquartered in Gray's Inn, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Richard Davies